You searched for "occlusion"

1034 results found

In conversation with Professor Harminder Singh Dua at OOC 2019

We chat to Professor Harminder Singh Dua at the Oxford Ophthalmological Congress 2019. Click the image below to see his answers to our questions.

In conversation with Robert McLaren at RCOphth 2019

In this video Professor Robert MacLaren talks to Eye News about the Keeler Lecture he gave on Gene Therapy for Retinitis Pigmentosa. Click the image below to see his answers to our questions.

In conversation with Professor Francesca Cordiero at RCOphth 2019

In this video Professor Francesca Cordiero talks to Eye News about the Duke Elder Lecture she gave on Detection of Apoptosing Retinal Cells (DARC) Development and Translation. Click the image below to see her answers to our questions.

In conversation with Robert Dempsey (2017)

The new Head of Global Ophthalmics at Shire met us at the 2017 Congress of the European Society of Cataract and Refractive Surgeons (ESCRS), to tell us why Shire feels the time is right to launch into ophthalmology. Click the...

GOSH (Great Ormond Street Hospital) Paediatric Ophthalmology Post-Graduate meeting - The Visiting Professors Day

Course Director: Prof Chris Lloyd, Consultant Ophthalmologist and Clinical Lead, Dept Ophthalmology, GOSH Event overview: The Visiting Professor's Day is a well-established GOSH Ophthalmology Unit tradition (dormant during the pandemic). It is all day postgraduate educational event aimed at those working with children with ophthalmic disorders including (but not exclusive to) Ophthalmologists, Orthoptists, Optometrists, Vision Scientists and academics. It will feature presentations from the GOSH ophthalmic and vision science team as well as talks from excellent external speakers including prominent "Visiting Professors" including Susmito Biswas (Cystinosis and the eye) Jane Ashworth (Advances in the ophthalmic management of the Mucopolysccharidoses) and Patrick Watts (Ophthalmic features of NAI; new RCOphth guidance).

What’s new in glaucoma? Clinical trials drive practice changes, surgical advancements gather pace

Rod McNeil reviews the latest developments in the treatment of glaucoma in the UK. Primary open-angle glaucoma (POAG), which accounts for over two-thirds of all glaucoma cases, has an estimated UK prevalence in 2017 of approximately 2% of people over...

Genetic profiling for personalised healthcare solutions in AMD – an update

Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

A look into the IOL space

Advances in the design and performance of intraocular lenses (IOLs) continue to be driven by demand for better outcomes, presbyopia correction and spectacle independence, alongside a better understanding of the dynamics of the crystalline lens, newer theories of accommodation and...

Update on emerging therapies for age-related macular degeneration

The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...

In conversation with Dr Monicah Bitok, Global Inclusive Eye Health Advisor (CBM)

Eye News spoke to Dr Monicah Bitok, Global Inclusive Eye Health Advisor with the Christian Blind Mission (CBM), about the rise in diabetes-related preventable blindness, systemic ophthalmic changes in low- and middle-income countries, and the impacts of a COVID-19-induced backlog...

The evolution and visual prognosis of glial proliferation of different grades after macular hole surgery

This retrospective research study aimed to investigate the evolution of glial proliferation of varying grades after successful idiopathic macular hole repair and its effects on foveal microstructure and best-corrected visual acuity (BCVA). Two-hundred and two eyes were enrolled in this...

OCTA in diabetic macular oedema treated with intravitreal aflibercept (DOCTA Study)

Central vision loss due to diabetic macular oedema (DME) can be attributed not only to presence of the macular oedema itself but also, in some cases, to alterations of the foveal avascular zone (FAZ). The DOCTA trial was a longitudinal,...